Bydureon
| Manufacturer | AstraZeneca |
| Website | N/A |
| API | Exenatide synthetic |
| Prescription | Yes |
| Treatment | Type 2 diabetes |
| Dose | 2.0 (mg) |
| Dosage Form | Microsphere suspension |
| Release Duration | 7 days |
| Excipients | Poly (D,L-lactide-coglycolide) |
| Product Label | |
| Orange Book App No. | 022200 |
CQA
| Quality attribute | N | Value | Std. dev. | Source |
|---|---|---|---|---|
| Particle Size - D50 (μm) | ████████ | ████████ | ████████ | ████████ |
| Pore Size - D50 (μm) | ████████ | ████████ | ████████ | ████████ |
| Roundness | ████████ | ████████ | ████████ | ████████ |
| Porosity (vol%) | ████████ | ████████ | ████████ | ████████ |
Images
